Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingtao Jin

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Cancers|January 11, 2025
Metabolic Signaling in the Tumor MicroenvironmentRyan Clay, Kunyang Li, Lingtao Jin
Journal of Immunology (Baltimore, Md. : 1950)|October 11, 2017
Naringenin Ameliorates Acute Inflammation by Regulating Intracellular Cytokine DegradationLingtao Jin, Wenfeng Zeng, Fayun Zhang, et al.
The FEBS Journal|September 4, 2021
PPARα at the crossroad of metabolic-immune regulation in cancerWenfeng Zeng, Xiaozhe Yin, Yunhan Jiang, et al.
STAR Protocols|March 31, 2021
<i>In vitro</i> and <i>ex vivo</i> evaluation of tumor-derived exosome-induced dendritic cell dysfunction in mouseWenfeng Zeng, Xiaozhe Yin, Yunhan Jiang, et al.
Pharmacological Research|August 7, 2018
Naringenin as a potential immunomodulator in therapeuticsWenfeng Zeng, Lingtao Jin, Fayun Zhang, et al.
NAR Genomics and Bioinformatics|August 1, 2022
SMGR: a joint statistical method for integrative analysis of single-cell multi-omics dataQianqian Song, Xuewei Zhu, Lingtao Jin, et al.
Cancer Research|March 26, 2009
Naringenin: a potential immunomodulator for inhibiting lung fibrosis and metastasisGangjun Du, Lingtao Jin, Xiaofen Han, et al.
NPJ Breast Cancer|July 10, 2021
Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1Haoming Chen, Ravi Padia, Tao Li, et al.
Cancer Gene Therapy|December 9, 2022
FAP is critical for ovarian cancer cell survival by sustaining NF-κB activation through recruitment of PRKDC in lipid raftsBin Li, Zuo Ding, Ozlem Calbay, et al.
Protein & Cell|July 13, 2011
Naringenin reduces lung metastasis in a breast cancer resection modelLei Qin, Lingtao Jin, Linlin Lu, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Cancers|January 11, 2025
Metabolic Signaling in the Tumor MicroenvironmentRyan Clay, Kunyang Li, Lingtao Jin
Journal of Immunology (Baltimore, Md. : 1950)|October 11, 2017
Naringenin Ameliorates Acute Inflammation by Regulating Intracellular Cytokine DegradationLingtao Jin, Wenfeng Zeng, Fayun Zhang, et al.
The FEBS Journal|September 4, 2021
PPARα at the crossroad of metabolic-immune regulation in cancerWenfeng Zeng, Xiaozhe Yin, Yunhan Jiang, et al.
STAR Protocols|March 31, 2021
<i>In vitro</i> and <i>ex vivo</i> evaluation of tumor-derived exosome-induced dendritic cell dysfunction in mouseWenfeng Zeng, Xiaozhe Yin, Yunhan Jiang, et al.
Pharmacological Research|August 7, 2018
Naringenin as a potential immunomodulator in therapeuticsWenfeng Zeng, Lingtao Jin, Fayun Zhang, et al.
NAR Genomics and Bioinformatics|August 1, 2022
SMGR: a joint statistical method for integrative analysis of single-cell multi-omics dataQianqian Song, Xuewei Zhu, Lingtao Jin, et al.
Cancer Research|March 26, 2009
Naringenin: a potential immunomodulator for inhibiting lung fibrosis and metastasisGangjun Du, Lingtao Jin, Xiaofen Han, et al.
NPJ Breast Cancer|July 10, 2021
Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1Haoming Chen, Ravi Padia, Tao Li, et al.
Cancer Gene Therapy|December 9, 2022
FAP is critical for ovarian cancer cell survival by sustaining NF-κB activation through recruitment of PRKDC in lipid raftsBin Li, Zuo Ding, Ozlem Calbay, et al.
Protein & Cell|July 13, 2011
Naringenin reduces lung metastasis in a breast cancer resection modelLei Qin, Lingtao Jin, Linlin Lu, et al.
Pageof 5